Next Article in Journal
Incremental Net Benefit and Incremental Cost-Effectiveness Ratio of COVID-19 Vaccination Campaigns: Systematic Review of Cost-Effectiveness Evidence
Next Article in Special Issue
Sph2(176–191) and Sph2(446–459): Identification of B-Cell Linear Epitopes in Sphingomyelinase 2 (Sph2), Naturally Recognized by Patients Infected by Pathogenic Leptospires
Previous Article in Journal
Evaluation of ROTARIX® Booster Dose Vaccination at 9 Months for Safety and Enhanced Anti-Rotavirus Immunity in Zambian Children: A Randomised Controlled Trial
Previous Article in Special Issue
A Pentavalent Shigella flexneri LPS-Based Vaccine Candidate Is Safe and Immunogenic in Animal Models
 
 
Article

Article Versions Notes

Vaccines 2023, 11(2), 348; https://doi.org/10.3390/vaccines11020348
Action Date Notes Link
article xml file uploaded 3 February 2023 08:14 CET Original file -
article xml uploaded. 3 February 2023 08:14 CET Update https://www.mdpi.com/2076-393X/11/2/348/xml
article pdf uploaded. 3 February 2023 08:15 CET Version of Record https://www.mdpi.com/2076-393X/11/2/348/pdf
article html file updated 3 February 2023 08:16 CET Original file -
article html file updated 1 March 2023 12:30 CET Update https://www.mdpi.com/2076-393X/11/2/348/html
Back to TopTop